Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST-1-reactive T cells

Microbiology and Immunology

Volumn 52, Issue 11, 2008, Pages 513-521

  Matsuda, Yoshio ^a   Kato, Hidehito ^a   Ono, Erina ^a   Kikuchi, Ken ^a   Muraoka, Mitsue ^b   Takagi, Koichiro ^b   Imanishi, Ken'ichi ^a   Itoh, Shun'ichi ^a   Itoh, Tatsuo ^a   Ogawa, Tetsuya ^a   Nitta, Kosaku ^a   Inokuchi, Sayaka ^c   Hibi, Toshifumi ^c   Ohta, Hiroaki ^a   Uchiyama, Takehiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Disseminated intravascular coagulation; Staphylococcus aureus; Toxic shock syndrome; V 2+ T cells

Indexed keywords

TOXIC SHOCK SYNDROME TOXIN 1; BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; SUPERANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MALE; PATIENT MONITORING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; SEPTIC SHOCK; T LYMPHOCYTE SUBPOPULATION;

STAPHYLOCOCCUS AUREUS;

ADULT; BACTERIAL TOXINS; ENTEROTOXINS; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS;

EID: 58249093556     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00071.x     Document Type: Article

References (36)

1. Todd J., Fishaut M., Kapral F., Welch T. (1978) Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 2: 1116-18
2. Shands K.N., Schmid G.P., Dan B.B. (1980) Toxic-shock syndrome in menstruating women: association with tampon use and S. aureus and clinical features in 52 cases. N Engl J Med 303: 1436-42.
3. Shlievert P.M., Shands K.N., Dan B.B., Schmid G.P., Nishimura R.D. (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 143: 509-16.
4. Bergdoll M.S., Crass B.A., Reiser R.F., Robins R.N., Davis J.P. (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1: 1017-21.
5. Bosley A.R.J, Bluett N.H., Sowden G. (1993) Toxic shock syndrome after elective minor dermatological surgery. BMJ 306: 386-87.
6. Bracero L., Bowe E. (1982) Postpartum toxic shock syndrome. Am J Obstet Gynecol 143: 478-79.
7. Keller J.L., Evan K.E., Wetmore R.F. (1999) Toxic shock syndrome after closed reduction of a nasal fracture. Otolaryngology-Head Neck Surg. 120(4): 569-70.
8. Ferguson M.A., Todd J.K. (1990) Toxic shock syndrome associated with staphylococcal aureus sinusitis in children. J Infect Dis 161: 953-55.
9. Cole R.P., Shakespear P.G. (1990) Toxic shock syndrome in scalded children. Burns 16: 221-4.
10. McAllister R.M., Mercer N.S., Morgan B.D., Sanders R. (1993) Early diagnosis of staphylococcal toxaemia in burned children. Burns 16: 22-5.
11. (1980) Centres for Disease Control (CDC) follow up on toxic-shock syndrome. MMWR 29: 442.
12. Tofte R.W., Williams D.N. (1981) Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA 246: 2163-67
13. Hajjeh R.A., Reingold A., Weil A., et al. (1999) Toxic shock syndrome in the United States: surveillance update 1979-1996. Emerg Inf Dis 5: 807-10.
14. Chesney P.J., Davis J.P., Purdy W.K., Wand P.J., Chesney R.W. (1981) Clinical manifestations of toxic shock syndrome. JAMA 246: 741-8.
15. White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. (1989) The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35
16. Kappler J., Kotzin B., Herron L., et al. (1989) Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811-13
17. Alouf J.E., Muller-Alouf H. (2003) Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol 292: 429-40.
18. Uchiyama T., Kamagata Y., Wakai M., Yoshioka M., Fujikawa H., Igarashi H. (1986) Study of the biological activities of toxic shock syndrome toxin-1: I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin. Microbiol Immunol 130: 469-83.
19. Uchiyama T., Imanishi K., Miyoshi-Akiyama T., Kato H. (2005) Staphylococcal superantigens and the diseases they cause. In: Alouf J.E., M.R. eds. The comprehensive source book of bacterial protein toxins, 3rd Edition. London, United Kingdom: Elsevier, pp. 830-43.
20. Uchiyama T., Tadakuma T., Imanishi K., et al. (1989) Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J Immunol 143: 3175-82.
21. Choi Y., Lafferty J.A., Clements J.R., et al. (1990) Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 172: 981-84.
22. Matsuda Y., Kato H., Yamada R., et al. (2003) Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor Vβ2-positive T cells. Emerg Infect Dis 9: 387-89.
23. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. (1998) Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351: 1614-19.
24. Takahashi N., Kato H., Imanishi K., et al. (2000) Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J Clin Invest 106: 1409-15.
25. + T cells demonstrated by cytokine production in response to a superantigen, TSST-1. Cell Immunol 222: 89-96.
26. Kikuchi K., Takahashi N., Piao C., Totsuka K., Nishida H., Uchiyama T. (2003) Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol 41: 3001-3007.
27. Kato H., Takahashi N., Arimura Y., Imanishi K., Nishida H., Uchiyama T. (2002) The percentage of superantigen-reactive T cells in peripheral blood significantly decreased before massively increasing in patients with neonatal TSS-like exanthematous disease in the early active phase. J Infect Chemother 8: 111-14.
28. Uchiyama T., Miyoshi-Akiyama, Ueshiba H. Superantigens from Gram-negative bacteria and the diseases they cause. Superantigens. Fraser J.D., ed. ASM Press. In press.
29. Kano H., Ito Y., Matsuoka K., et al. (2004) Critical role of T cell migration in bacterial superantigen-mediated shock in mice. Clin Immunol 110: 159-71
30. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349: 245-48.
31. + T cells by staphylococcal enterotoxin B. J Exp Med 172: 1091-1100.
32. + T cells. J Immunol 168: 3817-24.
33. Miller D., Urdaneta V., Weltman A. (2002) Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 51: 902.
34. Chang S., Sievert M.S., Hageman J.C. (2003) Infection with vancomycin-Resistant Staphylococcus aureus containing the vanA Resistance Gene. N Engl J Med 348: 1342-47.
35. Kacica M., McDonald L.C. (2004) Vancomycin-Resistant Staphylococcus aureus - New York, (2004). MMWR Morb Mortal Wkly Rep 53: 322-23.
36. Schlievert P.M., Tripp T.J., Peterson M.L. (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 42: 2875-76.